Offer - Urjas Oil for just Rs 1
Monocef O CV 200/125 Tablet (6) is a commercial drug that is prescribed in the form of Tablet. Monocef O CV 200/125 Tablet (6) also has some secondary and off-label uses. These are listed below.
The correct dosage of Monocef O CV 200/125 Tablet (6) depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Some other side effects of Monocef O CV 200/125 Tablet (6) have been listed ahead. Usually, these side effects of Monocef O CV 200/125 Tablet (6) go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Monocef O CV 200/125 Tablet (6)'s effect during pregnancy is Mild and Moderate while nursing. Warnings related to Monocef O CV 200/125 Tablet (6)'s effects on the liver, heart and kidney, if any, have been listed below.
Monocef O CV 200/125 Tablet (6) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Monocef O CV 200/125 Tablet (6) in conditions like Jaundice. Other conditions have been mentioned below in the Monocef O CV 200/125 Tablet (6) contraindications section.
Drug interactions for Monocef O CV 200/125 Tablet (6) have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Monocef O CV 200/125 Tablet (6) is considered safe while driving, and is addictive.
Monocef O CV 200/125 Tablet (6) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Is the use of Monocef O CV 200/125 Tablet (6) safe for pregnant women?
Monocef O CV rarely shows harmful effects in in pregnant ladies. Even if it does, the effects are mild
Is the use of Monocef O CV 200/125 Tablet (6) safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Monocef O CV. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Monocef O CV 200/125 Tablet (6) on the Kidneys?
There can be some harmful effects on your kidneys after taking Monocef O CV. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Monocef O CV 200/125 Tablet (6) on the Liver?
Monocef O CV may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Monocef O CV 200/125 Tablet (6) on the Heart?
Monocef O CV has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Monocef O CV 200/125 Tablet (6) unless your doctor advises you to do so -
Is this Monocef O CV 200/125 Tablet (6) habit forming or addictive?
No, you will not get addicted to Monocef O CV 200/125 Tablet (6).
Interaction between Food and Monocef O CV 200/125 Tablet (6)
Taking Monocef O CV 200/125 Tablet (6) with food does not cause any problems.
Interaction between Alcohol and Monocef O CV 200/125 Tablet (6)
It is difficult to say anything about the effect of Monocef O CV 200/125 Tablet (6) and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311
